Resources:FDA Public Health Advisory. "Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome." U.S. Food and Drug Administration/Center for Drug Evaluation and Research. July 19, 2006.Doreen, Jennifer Corbett. "FDA warns on migraine drugs, antidepressants taken together." MarketWatch. July 19, 2006.
© Teri Robert, 2007